PRESCRIPTION PATTERN IN COVID-19 PATIENTS ADMITTED TO A TERTIARY CARE CENTER IN KERALA

Author:

SUSAN JOSEPH ,SAINATHAN R

Abstract

Objectives: The objectives of the study were to analyze the prescribing pattern in COVID-19 patients and to identify the most commonly prescribed drugs and their routes. Methods: A hospital-based retrospective observational study was conducted based on data of COVID-19 positive patients admitted over a period of 6 months, from May 1, 2020, to October 31, 2020. Relevant data were collected from medical records library. Results: The prescriptions of 1223 COVID-19 positive patients were analyzed. Among them 63.7% were men (n=780). The mean age was 46.5 years. 49.9% (n=611) of our patients were mild cases, categorized as category A. 41.2% (n=505) were category B, and 8.7% came under the severe disease category C. Duration of hospital stay of the patients ranged from 1 to 44 days with a mean duration of 9 days. The most prescribed medication was paracetamol which was prescribed to 55% (n=679) of patients. From the 488 (39.9%) patients who received some antibiotic, the most frequently prescribed was azithromycin (80.1%) followed by ceftriaxone (17.2%) and cefotaxime (3.07%). 18.5% of patients were prescribed anticoagulants, the most common being LMWH-enoxaparin. 17.9% of patients received some systemic corticosteroids. Antivirals prescribed were favipiravir (7.4%), oseltamivir (4.7%), and 0.8% remdesivir. Conclusion: Different drugs belonging to different groups have been prescribed, for symptomatic treatment of disease and its complications as a single effective drug has not been discovered. Almost all the drugs prescribed were generic drugs and were from the Essential List of Medicines-2015.

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference26 articles.

1. Hui DS, Madani TA, Ntoumi F, Kock R, Dar O, Kock R, et al. The continuing 2019-nCoV epidemic threat of novel Coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264-6. doi: 10.1016/j.ijid.2020.01.009, PMID 31953166

2. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel Coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020;15:e0234765. doi: 10.1371/journal.pone.0234765, PMID 32574165, PMCID 7310678

3. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA 2020;323:1499-500. doi: 10.1001/jama.2020.3633, PMID 32159735

4. World Health Organization. Statement on the Second Meeting of the International Health Regulations. Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). Geneva: World Health Organization; 2005.

5. Covid-19 Body Count: India’s Low Mortality Rate and the Contrasting Pictures of Two States. News. Available from: https://www.news18. com/news/india/covid-19-body-count-indias-low-mortality-rate-and-the-contrasting-pictures-of-two-states-2578653.html [Retrieved on 2020 Apr 16], [Last accessed on 2023 Mar 20].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3